Do you know anyone suffering from psoriasis? Call Today – 855.554.6374
note: Qualified study participants will receive study drug, related testing, and compensation for their time and travel.
Clinical Trial Government Identifier #NCT03384745
Sponsor: Bond Avillion Development
|Genders eligible for study: Male/Female||Ages eligible for study: 18 – 75 years|
|NEW STUDY – NOW ENROLLING – Moderate to Severe plaque psoriasis present for at least 6 months.||December 2018 – TBD|